Home - Products - Microbiology/Virology - HBV - HBV-IN-37

HBV-IN-37

CAS No. 380483-01-2

HBV-IN-37( —— )

Catalog No. M37076 CAS No. 380483-01-2

HBV-IN-37 is an HBV inhibitor with an EC50 value of 10 μM and can be used for hepatitis B disease-related research.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	61	In Stock
10MG	100	In Stock
25MG	162	In Stock
50MG	241	In Stock
100MG	350	In Stock
500MG	795	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

HBV-IN-37
Note

Research use only, not for human use.
Brief Description

HBV-IN-37 is an HBV inhibitor with an EC50 value of 10 μM and can be used for hepatitis B disease-related research.
Description

HBV-IN-37 is an inhibitor of HBV with an EC50 value of 10 μM.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Microbiology/Virology
Target

HBV
Recptor

HBV
Research Area

——
Indication

——

Chemical Information

CAS Number

380483-01-2
Formula Weight

439.96
Molecular Formula

C23H22ClN3O2S
Purity

>98% (HPLC)
Solubility

——
SMILES

C(N1C(C=2C(=NN(C2)C3=CC=CC=C3)C4=CC=C(Cl)C=C4)SCC1=O)C5CCCO5
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Burfiralimab

Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) targeted against waveform proteins, exhibiting anti-HBV properties and potential applications in rheumatoid arthritis research.
HBV-IN-37

HBV-IN-37 is an HBV inhibitor with an EC50 value of 10 μM and can be used for hepatitis B disease-related research.
?-Thujaplicinol

?-Thujaplicinol, a hydroxylated thujaplicinone isolated from western red cedar heartwood, has antiviral activity, inhibits hepatitis B virus replication by blocking viral ribonuclease H activity, and can be used in the study of viral infections.

Sign In Join Free